GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Smruthi Organics Ltd (BOM:540686) » Definitions » Price-to-Owner-Earnings

Smruthi Organics (BOM:540686) Price-to-Owner-Earnings : (As of Jun. 17, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Smruthi Organics Price-to-Owner-Earnings?

As of today (2024-06-17), Smruthi Organics's share price is ₹168.55. Smruthi Organics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Smruthi Organics's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Smruthi Organics was 72.49. The lowest was 1.97. And the median was 18.09.


BOM:540686's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 25.33
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-17), Smruthi Organics's share price is ₹168.55. Smruthi Organics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹3.14. Therefore, Smruthi Organics's PE Ratio for today is 53.68.

As of today (2024-06-17), Smruthi Organics's share price is ₹168.55. Smruthi Organics's EPS without NRI for the trailing twelve months (TTM) ended in was ₹3.14. Therefore, Smruthi Organics's PE Ratio without NRI for today is 53.68.

During the past 13 years, Smruthi Organics's highest PE Ratio without NRI was 256.67. The lowest was 3.55. And the median was 24.38.


Smruthi Organics Price-to-Owner-Earnings Historical Data

The historical data trend for Smruthi Organics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smruthi Organics Price-to-Owner-Earnings Chart

Smruthi Organics Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.89 14.62 - 21.74 -

Smruthi Organics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.74 - - - -

Competitive Comparison of Smruthi Organics's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Smruthi Organics's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Smruthi Organics's Price-to-Owner-Earnings falls into.



Smruthi Organics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Smruthi Organics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=168.55/-2.31
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Smruthi Organics  (BOM:540686) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Smruthi Organics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Smruthi Organics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Smruthi Organics (BOM:540686) Business Description

Traded in Other Exchanges
N/A
Address
165-A, Balaji Bhavan, 1st Floor, Railway Lines, Solapur, MH, IND, 413 001
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium and many more. It has two segments Bulk Drugs and Drugs Intermediates (API) and Formulation. it generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment.

Smruthi Organics (BOM:540686) Headlines

No Headlines